Sylvie Lorenzen Selected Research

Squamous Cell Neoplasms (Squamous Cell Cancer)

1/2018

Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvie Lorenzen Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 01/2008
26	Adenocarcinoma 03/2024 - 09/2007
13	Stomach Neoplasms (Stomach Cancer) 03/2024 - 07/2011
7	Colorectal Neoplasms (Colorectal Cancer) 07/2022 - 01/2018
6	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2011
5	Microsatellite Instability 08/2023 - 12/2021
5	Breast Neoplasms (Breast Cancer) 06/2023 - 02/2011
5	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 03/2015
4	Carcinoma (Carcinomatosis) 01/2022 - 10/2010
1	Febrile Neutropenia 11/2023
1	Mucositis 11/2020
1	Fibrosis (Cirrhosis) 10/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2019
1	Acne Vulgaris 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Necrosis 01/2018
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Lymphatic Metastasis 12/2017
1	Disease Progression 12/2017
1	Esophageal Squamous Cell Carcinoma 01/2016
1	Vomiting 02/2009
1	Nausea 02/2009

Drug/Important Bio-Agent (IBA)

10	Trastuzumab (Herceptin)FDA Link 03/2024 - 07/2011
8	Fluorouracil (Carac)FDA LinkGeneric 11/2023 - 12/2011
7	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2011
7	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
6	RamucirumabIBA 03/2024 - 06/2015
6	Leucovorin (Folinic Acid)FDA Link 11/2023 - 12/2011
6	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 12/2011
6	Cetuximab (Erbitux)FDA Link 01/2022 - 12/2011
6	Capecitabine (Xeloda)FDA Link 01/2020 - 03/2015
5	Docetaxel (Taxotere)FDA Link 11/2023 - 12/2016
5	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 02/2009
4	PlatinumIBA 08/2023 - 01/2020
4	Paclitaxel (Taxol)FDA LinkGeneric 06/2023 - 06/2015
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 07/2011
3	NivolumabIBA 03/2024 - 06/2020
3	human ERBB2 proteinIBA 06/2023 - 07/2011
3	Monoclonal AntibodiesIBA 06/2023 - 07/2011
3	pembrolizumabIBA 01/2023 - 01/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 01/2008
2	Irinotecan (Camptosar)FDA LinkGeneric 06/2023 - 01/2018
2	IpilimumabIBA 01/2022 - 06/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2015 - 01/2008
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2023
1	trifluridine tipiracil drug combinationIBA 11/2023
1	atezolizumabIBA 11/2023
1	taxaneIBA 08/2023
1	DNA (Deoxyribonucleic Acid)IBA 07/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Panitumumab (Vectibix)FDA Link 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	avelumabIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Circulating Tumor DNAIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Everolimus FDA Link 11/2020
1	MucinsIBA 10/2020
1	Cytostatic AgentsIBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	Taxoids (Taxanes)IBA 01/2020
1	Vitamin K 1 (Phylloquinone)FDA LinkGeneric 01/2019
1	Doxycycline (Periostat)FDA LinkGeneric 01/2019
1	VemurafenibIBA 01/2018
1	PEGPH20IBA 01/2018
1	SirtuinsIBA 01/2018
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2018
1	Epirubicin (Ellence)FDA LinkGeneric 12/2016
1	Tyrosine Kinase InhibitorsIBA 03/2015
1	Lapatinib (GW572016)FDA Link 03/2015
1	Cadherins (E-Cadherin)IBA 12/2011
1	vadimezanIBA 03/2011
1	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 03/2011
1	pimonidazoleIBA 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2011
1	Aprepitant (Emend)FDA Link 02/2009
1	Integrin alphaVbeta3IBA 01/2008

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 03/2024 - 02/2009
18	Therapeutics 03/2024 - 01/2017
11	Neoadjuvant Therapy 08/2023 - 09/2007
7	Immunotherapy 01/2022 - 01/2018
4	Chemoradiotherapy 01/2023 - 06/2011
3	Aftercare (After-Treatment) 11/2023 - 03/2011
2	Combination Drug Therapy (Combination Chemotherapy) 03/2024 - 04/2014
2	Induction Chemotherapy 09/2020 - 06/2011
1	Combined Modality Therapy 11/2022
1	Palliative Care (Palliative Therapy) 12/2021
1	Hyperthermic Intraperitoneal Chemotherapy 10/2021
1	Radiotherapy 09/2020
1	Intravenous Infusions 12/2016
1	Molecular Targeted Therapy 01/2008